InMed Pharmaceuticals Amends Merger Agreement with Mentari Therapeutics

InMed Pharmaceuticals filed an amendment to its previously signed merger agreement with Mentari Therapeutics, Inc. This document confirms the approval of the transaction by the relevant boards of directors for Parent and Merger Subs.